Medical News Today: Depression: Esketamine trial leaves 'more questions than answers'
A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?
from Featured Health News from Medical News Today http://bit.ly/2VKK2uy
from Featured Health News from Medical News Today http://bit.ly/2VKK2uy
Comments
Post a Comment